Flow Cytometry Market - By Products and Services (Reagents and Consumables, Instruments), By Technology (Cell-Based, Bead-Based), By Application (Immunophenotyping), By Usage (Research, Clinical), By End-use (Hospitals), & Forecast, 2023 – 2032

Flow Cytometry Market Size

Flow Cytometry Market size valued at USD 4.9 billion in 2022 and is estimated to register over 8.4% CAGR between 2023 and 2032. Technological advancements, growing biomedical research, increasing focus on personalized medicine, rise in cancer research and immunotherapy and growing investments and collaborations among key industry players are primary growth factors that are impacting the market revenue. Increase in applications of flow cytometry in clinical diagnostics such as immunophenotyping of cells for diagnosing hematological disorders, monitoring HIV/AIDS progression, detecting minimal residual disease in leukemia, and assessing immune cell function among others.
 

Rising adoption flow cytometry technique in pharma companies for drug discovery and development processes, including target identification, lead compound screening, toxicity assessment, and immunogenicity testing are further fueling the flow cytometry market growth. Furthermore, rising automation level of these systems and growing demand for point-of-care diagnostics are also propelling the market expansion. Thus, the increasing demand for precise cellular analysis, expanding research areas, and rise in prevalence of infectious diseases among other variables are adding to product adoption rate.
 

Flow cytometry is a key technique used in biomedical research and clinical diagnostics to analyse and distinguish individual cells or particles in a heterogeneous mixture. It provides quantitative and qualitative information about various cellular properties, such as size, shape, granularity, and the presence or absence of specific biomarkers on the cell surface or within the cell.

High instrument cost, complexities associated with the technique, and limited standardization among other factors are likely to hamper the product adoption rate. The flow cytometry instruments and reagents used in the process can be expensive, making them less accessible to smaller research laboratories and resource-limited facilities. The high cost of entry and substantial maintenance expenses can limit the adoption of flow cytometry systems, thereby hindering the flow cytometry market growth. Further, availability of alternative technologies and stringent regulatory guidelines are anticipated to restrain the industry growth.
 

COVID-19 Impact

Flow cytometry technique has proven to be a beneficial approach in vaccine development and monitoring and in various diagnostic applications, including immune cell profiling and identifying specific cell populations associated with COVID-19 infections. Due to its ability to analyse immune cell populations and assess immune function, flow cytometry technique became an essential tool in studying COVID-19 immunology, thus increased the demand for flow cytometry instruments and reagents. Similarly, research funding and collaboration among various end-users such as academic institutes, clinical laboratories further contributed to industry growth.
 

Flow Cytometry Market Trends

Technological advancements have significantly improved flow cytometry instruments, enhancing their capabilities and performance. High-parameter and multiplexing capabilities, automation and high-throughput analysis, imaging flow cytometry and improvements in optics, detectors, and signal processing are among the key parameters that are anticipated to fuel the product adoption rate. Flow cytometry instruments have evolved to accommodate higher parameter analysis, allowing simultaneous detection of more fluorescent markers.
 

In addition, major companies around the world are focusing on using flow cytometry while conducting research related to different fields. For instance, in October 2021, BD Life Sciences-Biosciences, in partnership with the Christian Medical College Vellore India, launched its second (CoE) center of excellence related to flow cytometry for clinical research. Such developments by leading players will enhance the flow cytometry systems adoption rate, thereby augmenting the market statistics.
 

Flow Cytometry Market Analysis

Based on products and services, the flow cytometry market is categorized into reagents and consumables, instruments, software, services, and accessories. The instrument segment accounted around USD 1.6 billion in 2022. The high growth rate is owing to wide application range, technological advancements, and increased research spending by multinational companies. Additionally, the compact or small-sized cytometers are predicted to witness healthy growth in coming years owing to cost-effectiveness and user-friendliness of the devices.

Based on technology, the flow cytometry market is segmented into bead-based and cell-based segments. The cell-based segment accounted for dominating revenue share in 2022 and is expected to reach around USD 8.5 billion by 2032. Growing demand for early diagnosis of several diseases including HIV and cancer, rise in adoption of cell-based systems and increase in awareness related to benefits associated with cell-based assays are key pointers adding to market growth. However, robust application range including biomedical research and increase in usage of these systems in monitoring the progress of drug treatment are other factors that are contributing to its dominance.


Based on application, the flow cytometry market is categorized into immunophenotyping, cell sorting, cell counting, cell cycle analysis, and others. The immunophenotyping segment exceeded USD 1.8 billion in 2022. Immunophenotyping is a process that uses antibodies to distinguish and identify cells based on different types of markers and antigens that are present on their surface. The high growth is attributed to increased use of this technique in numerous research activities including diagnosis of different diseases such as oncology, inherited immunodeficiencies, esoteric testing, and certain variants of leukemia and lymphoma among others.
 

Based on usage, the flow cytometry market is categorized into research, clinical and industrial segments. The clinical segment is set to reach USD 4.6 billion by 2032. High segmental share is primarily attributed to rise in R&D activities related to cancer and various infectious diseases such as SARS-CoV-2 (coronavirus). Further, novel product launches incorporating technological advancements is among the key strategy adopted by industry players to augment the product adoption rate. Thus, improved product offering, shorter turnaround time, and advancements in monoclonal antibody production will further aid in diagnosis of autoimmune disease and organ transplantation conditions.
 

Learn more about the key segments shaping this market

 Download Free Sample

Based on end-use, the flow cytometry market is bifurcated into commercial organizations, hospitals, academic and research institutes, and clinical testing labs. The academic and research institutes segment accounted for major share in 2022 and is projected to reach around USD 3.5 billion by 2032. This technology helps in understanding the physical and chemical properties of the cells. Hence, increased R&D spending on research pertaining to various fields including marine biology, pathology, immunology and molecular biology among others is contributing to higher adoption of flow cytometry in educational and research activities.
 

North America flow cytometry market is expected to grow at 7.8% CAGR through 2032. The high regional growth is attributed to expanding application prospect of flow cytometry in clinical settings, high disease burden rate, technological advancements, and increased R&D spending, among others. Facilitative government support via grants, favorable business environment, presence of large number of contract research organizations and established players are other attributes that are anticipated to propel the market growth. Moreover, the region is home to high incidence and prevalence of cancer patients that makes it mandatory for pharma companies to focus on development of better treatment options for different target diseases.
 

Flow Cytometry Market Share

Some of the major players operating in the flow cytometry market include

• Sony Biotechnology, Inc.
• Becton
• Dickinson and Company
• Danaher Corp
• Thermo Fisher Scientific, Inc.
• Agilent Technologies, Inc.
• Miltenyi Biotec, Inc.
• Bio-Rad Laboratories, Inc.
• Sysmex Corporation
• Luminex Corporation 

These participants are involved in strategic developments such as mergers and acquisitions, novel product launch, collaboration, and research and development to improve their revenue generating capabilities.
 

Flow Cytometry Industry News:

• In September 2022, Becton, Dickinson and Company launched BD Research Cloud. It is designed with a focus to streamline the workflow for research personnel working in different disciplines such as virology and immunology. This development will allow the company to improve their flow cytometry software offerings and enhance their business revenue.
   
• In June 2021, Thermo Fisher Scientific Inc. launched its Invitrogen Attune CytPix Flow Cytometer. It is an imaging-enabled flow cytometer system that combines high-speed camera with acoustic focusing flow cytometry technology. This strategic development helped the company to expand their portfolio and improve their market presence.
   

This flow cytometry market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

By Products and Services

• Reagents and Consumables
• Instruments
• Cell Analyzers
• Cell Sorters

• Software
• Services
• Accessories

By Technology

• Cell-based
• Bead-based

By Application

• Immunophenotyping
• Cell Sorting
• Cell Counting
• Cell Cycle Analysis
• Apoptosis
• Cell Proliferation Assays
• Intracellular Calcium Flux

• Others

By Usage

• Research
• Clinical
• Cancer Diagnostics
• Hematology
• Immunodeficiency
• Others

• Industrial

By End-use

• Commercial Organizations
• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organizations

• Hospitals
• Academic and Research Institutes
• Clinical Testing Labs

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
  • Sweden
  • The Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Indonesia
  • Philippines
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Columbia
  • Peru
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • Israel
  • Iran